This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 03/05/2024
Location: Virtual
Subject: Coalition for Health AI Webinar
FDA Participant/Group: TROY TAZBAZ;
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Event Date: 03/07/2024
Location: Virtual
Subject: Initiatives and Collaboration
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Anat Boehm-Cagan, Michal Hirsch-Vexberg, Osnat Luxenburg, Tal Naggan (Medical Technology, Health Information and Research Directorate, Ministry of Health, Israel);

Event Date: 03/09/2024
Location: Virtual
Subject: The International Society for Biopharmaceutical Statistics: The 7th Symposium on Statistical Innovation for Medical Product Development; Speaker: Evidence Generation Continues to Evolve
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other registered participants

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 03/08/2024
Location: Virtual
Subject: Food Chemical Safety Initiatives; Alliance for Stronger FDA Webinar
FDA Participant/Group: CONRAD CHOINIERE; KRISTI MULDOON JACOBS;
Non FDA Participant/Group: Industry, academia, trade associations, and media

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/07/2024
Location: Virtual
Subject: Evaluation Reference Group, WHO Member State Mechanism on Substandard and Falsified Medicines Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Evaluation Reference Group, WHO Member State Mechanism on Substandard and Falsified Medicines

Event Date: 03/07/2024
Location: Virtual
Subject: Substandard and Falsified Medicines and the WHO Certificate of Pharmaceutical Product
FDA Participant/Group: N/A
Non FDA Participant/Group: Dr. Richard Wilder (O'Neill Institute for National and Global Health Law);

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/06/2024
Location: Virtual
Subject: Barth Syndrome Foundation Listening Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Emily Milligan, Kate McCurdy (Barth Syndrome Foundation);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/04/2024
Location: North Bethesda, MD
Subject: International Foundation Process Analytical Chemistry: Advanced Manufacturing and Complex Biologic Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 03/05/2024
Location: Arlington, VA
Subject: America’s Blood Centers: Regulation of Cell Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 03/05/2024
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and public stakeholders

Event Date: 03/05/2024
Location: Arlington, VA
Subject: America’s Blood Centers: Update from the FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 03/06/2024
Location: Virtual
Subject: Mount Sinai Morningside and Mount Sinai West Hospitals - Internal Medicine Grand Rounds: Accelerating the Pace of Progress in Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare stakeholders

Event Date: 03/08/2024
Location: New York, NY
Subject: Memorial Sloan Kettering Cancer Center – Medicine Grand Rounds: Facilitating the Development of Advanced Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare stakeholders

Event Date: 03/08/2024
Location: Virtual
Subject: Mayo Clinic Rochester’s Hematology/Oncology Career Development Retreat: Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/08/2024
Location: Virtual
Subject: Johns Hopkins Healthcare Business Conference: Transforming Human Health with Medical Device Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 03/05/2024
Location: Washington, DC
Subject: Overview of FDA Human Foods Program Reorganization
FDA Participant/Group: PATRICIA HANSEN;
Non FDA Participant/Group: Erin Malawer (AllergyStrong); Bob Earl and several other members (Food Allergy Research and Education (FARE))

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/07/2024
Location: Virtual
Subject: Nicotine Content and CTP’s Five-Year Strategic Plan
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of the Cigar Rights Association (CRA)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event